Evaluating the Role of Radiotherapy in Pancreatic Cancer Treatment

A recent study published in the Annals of Surgical Oncology evaluated the effectiveness of adding radiotherapy to adjuvant chemotherapy for patients with resected pancreatic cancer who had undergone neoadjuvant chemotherapy. The results indicated no significant survival benefit from the addition of radiotherapy. This finding can influence treatment protocols, suggesting that adjuvant chemotherapy alone may be sufficient, potentially reducing the treatment burden on patients. For more details, refer to the study here.
https://link.springer.com/article/10.1245/s10434-024-15157-4